The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for ...

New cases of HIV-AIDS infections in the country are on the rise, mainly among the youths, with efforts to reduce the numbers ...

Groundbreaking twice-a-year HIV drug that could stop transmission approved - It's unclear how many people in the US and ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

With a Sh31 billion funding gap due to the pulling out of support from major donors, the government was expected to step up.